Steinberg RL - Search Results

1

Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease.

Steinberg RL, Thomas LJ, O'Donnell MA. Steinberg RL, et al. Bladder Cancer. 2015 Oct 26;1(2):105-116. doi: 10.3233/BLC-150015. Bladder Cancer. 2015. PMID: 27376112 Free PMC article. Review.

2

Intravesical and alternative bladder-preservation therapies in the management of non-muscle-invasive bladder cancer unresponsive to bacillus Calmette-Guérin.

Steinberg RL, Thomas LJ, Nepple KG. Steinberg RL, et al. Urol Oncol. 2016 Jun;34(6):279-89. doi: 10.1016/j.urolonc.2015.12.004. Epub 2016 Jan 14. Urol Oncol. 2016. PMID: 26777259 Review.

3

Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer.

Velaer KN, Steinberg RL, Thomas LJ, O'Donnell MA, Nepple KG. Velaer KN, et al. Among authors: steinberg rl. Curr Urol Rep. 2016 May;17(5):38. doi: 10.1007/s11934-016-0594-2. Curr Urol Rep. 2016. PMID: 26968418 Review.

4

Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease.

Steinberg RL, Thomas LJ, Mott SL, O'Donnell MA. Steinberg RL, et al. Bladder Cancer. 2016 Apr 27;2(2):215-224. doi: 10.3233/BLC-150039. Bladder Cancer. 2016. PMID: 27376140 Free PMC article.

5

Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non-muscle-invasive bladder cancer.

Steinberg RL, Brooks NA, Thomas LJ, Mott SL, O'Donnell MA. Steinberg RL, et al. Urol Oncol. 2017 May;35(5):201-207. doi: 10.1016/j.urolonc.2016.11.016. Epub 2016 Dec 29. Urol Oncol. 2017. PMID: 28041998 Clinical Trial.

6

Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.

Steinberg RL, Nepple KG, Velaer KN, Thomas LJ, O'Donnell MA. Steinberg RL, et al. Urol Oncol. 2017 Dec;35(12):670.e7-670.e14. doi: 10.1016/j.urolonc.2017.07.024. Epub 2017 Aug 8. Urol Oncol. 2017. PMID: 28801026

7

Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer.

Steinberg RL, Thomas LJ, O'Donnell MA. Steinberg RL, et al. Eur Urol Focus. 2018 Jul;4(4):503-505. doi: 10.1016/j.euf.2018.07.005. Epub 2018 Jul 14. Eur Urol Focus. 2018. PMID: 30017900 Review.

8

Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer.

Steinberg RL, Thomas LJ, O'Donnell MA, Nepple KG. Steinberg RL, et al. Bladder Cancer. 2015 Apr 30;1(1):65-72. doi: 10.3233/BLC-150008. Bladder Cancer. 2015. PMID: 30561441 Free PMC article.

9

Severe Infectious Complications of Intravesical Bacillus Calmette-Guérin: A Case Series of 10 Patients.

Yong C, Steinberg RL, O'Donnell MA. Yong C, et al. Among authors: steinberg rl. Urology. 2020 Mar;137:79-83. doi: 10.1016/j.urology.2019.10.013. Epub 2019 Nov 6. Urology. 2020. PMID: 31705946

10

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.

Steinberg RL, Thomas LJ, Brooks N, Mott SL, Vitale A, Crump T, Rao MY, Daniels MJ, Wang J, Nagaraju S, DeWolf WC, Lamm DL, Kates M, Hyndman ME, Kamat AM, Bivalacqua TJ, Nepple KG, O'Donnell MA. Steinberg RL, et al. J Urol. 2020 May;203(5):902-909. doi: 10.1097/JU.0000000000000688. Epub 2019 Dec 10. J Urol. 2020. PMID: 31821066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters